DUBLIN, June 23, 2021 /PRNewswire/ -- Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced its participation at the American Diabetes Association (ADA) 81th scientific ...
Medtronic has launched a new line of insulin infusion hardware in Europe that effectively doubles its lifespan, with sets capable of being worn for up to seven days at a time. Typically, people with ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A novel extended-wear insulin infusion set was usable ...
For the first time, real-world data on the Medtronic Extended Infusion™ Set was presented (n=108) and the analysis showed an average infusion set wear time of 6.74 days. Almost half (48.2%) of the ...
Medtronic plc MDT has recently launched the Medtronic Extended infusion set in select European countries. This set was developed in partnership with ConvaTec's Unomedical subsidiary, a well-known ...
The thin plastic tubing of infusion sets that connect insulin pumps to the body typically need to be changed every two or three days—but a new version in the U.S. more than doubles that timespan. The ...
Certain Medtronic MiniMed Paradigm Insulin Infusion sets are being recalled, the Food and Drug Administration announced on Friday. The affected products were manufactured between October 2001 and June ...
Editor's note: This story was updated April 25, 2023 to reflect important news regarding Medtronic's warning letter for the diabetes business. One of the Medtronic Growth Catalysts to Watch for in ...
The FDA approved Medtronic's latest MiniMed insulin pump system, the company announced late last week. Indicated for individuals with type 1 diabetes ages 7 and older, the MiniMed 780G system pairs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback